Reply to the article "Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases" by J.-J. Body et al. (Ann Oncol 2007; 18 : 1165-1171)


Yaman E., Benekli M., Coskun U., Ozturk B., Kaya A. O. , Yildiz R., ...More

ANNALS OF ONCOLOGY, vol.19, no.2, pp.397-398, 2008 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Letter
  • Volume: 19 Issue: 2
  • Publication Date: 2008
  • Doi Number: 10.1093/annonc/mdm577
  • Title of Journal : ANNALS OF ONCOLOGY
  • Page Numbers: pp.397-398